Cargando…

Crystal structures of N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-2-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide and N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-4-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide

The title compounds, C(32)H(28)N(10)O(4)· unknown solvent, (I), and C(32)H(28)N(10)O(4), (II), are pyrazine-2,3,5,6-tetra­carboxamide derivatives. In (I), the substituents are (pyridin-2-ylmeth­yl)carboxamide, while in (II), the substituents are (pyridin-4-ylmeth­yl)carboxamide. Both compounds cryst...

Descripción completa

Detalles Bibliográficos
Autores principales: Cati, Dilovan S., Stoeckli-Evans, Helen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290586/
https://www.ncbi.nlm.nih.gov/pubmed/28217363
http://dx.doi.org/10.1107/S205698901700127X
_version_ 1782504662606282752
author Cati, Dilovan S.
Stoeckli-Evans, Helen
author_facet Cati, Dilovan S.
Stoeckli-Evans, Helen
author_sort Cati, Dilovan S.
collection PubMed
description The title compounds, C(32)H(28)N(10)O(4)· unknown solvent, (I), and C(32)H(28)N(10)O(4), (II), are pyrazine-2,3,5,6-tetra­carboxamide derivatives. In (I), the substituents are (pyridin-2-ylmeth­yl)carboxamide, while in (II), the substituents are (pyridin-4-ylmeth­yl)carboxamide. Both compounds crystallize in the monoclinic space group P2(1)/n, with Z′ = 1 for (I), and Z′ = 0.5 for (II). The whole mol­ecule of (II) is generated by inversion symmetry, the pyrazine ring being situated about a center of inversion. In (I), the four pyridine rings are inclined to the pyrazine ring by 83.9 (2), 82.16 (18), 82.73 (19) and 17.65 (19)°. This last dihedral angle involves a pyridine ring that is linked to the adjacent carboxamide O atom by an intra­molecular C—H⋯O hydrogen bond. In compound (II), the unique pyridine rings are inclined to the pyrazine ring by 33.3 (3) and 81.71 (10)°. There are two symmetrical intra­molecular C—H⋯O hydrogen bonds present in (II). In the crystal of (I), mol­ecules are linked by N—H⋯O and N—H⋯N hydrogen bonds, forming layers parallel to (10-1). The layers are linked by C—H⋯O and C—H⋯N hydrogen bonds, forming a three-dimensional framework. In the crystal of (II), mol­ecules are linked by N—H⋯N hydrogen bonds, forming chains propagating along the [010] direction. The chains are linked by a weaker N—H⋯N hydrogen bond, forming layers parallel to the (101) plane, which are in turn linked by C—H⋯O hydrogen bonds, forming a three-dimensional structure. In the crystal of compound (I), a region of disordered electron density was treated with the SQUEEZE routine in PLATON [Spek (2015 ▸). Acta Cryst. C71, 9–18]. Their contribution was not taken into account during refinement. In compound (II), one of the pyridine rings is positionally disordered, and the refined occupancy ratio for the disordered C(ar)—C(ar)—N(py) atoms is 0.58 (3):0.42 (3).
format Online
Article
Text
id pubmed-5290586
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-52905862017-02-17 Crystal structures of N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-2-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide and N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-4-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide Cati, Dilovan S. Stoeckli-Evans, Helen Acta Crystallogr E Crystallogr Commun Research Communications The title compounds, C(32)H(28)N(10)O(4)· unknown solvent, (I), and C(32)H(28)N(10)O(4), (II), are pyrazine-2,3,5,6-tetra­carboxamide derivatives. In (I), the substituents are (pyridin-2-ylmeth­yl)carboxamide, while in (II), the substituents are (pyridin-4-ylmeth­yl)carboxamide. Both compounds crystallize in the monoclinic space group P2(1)/n, with Z′ = 1 for (I), and Z′ = 0.5 for (II). The whole mol­ecule of (II) is generated by inversion symmetry, the pyrazine ring being situated about a center of inversion. In (I), the four pyridine rings are inclined to the pyrazine ring by 83.9 (2), 82.16 (18), 82.73 (19) and 17.65 (19)°. This last dihedral angle involves a pyridine ring that is linked to the adjacent carboxamide O atom by an intra­molecular C—H⋯O hydrogen bond. In compound (II), the unique pyridine rings are inclined to the pyrazine ring by 33.3 (3) and 81.71 (10)°. There are two symmetrical intra­molecular C—H⋯O hydrogen bonds present in (II). In the crystal of (I), mol­ecules are linked by N—H⋯O and N—H⋯N hydrogen bonds, forming layers parallel to (10-1). The layers are linked by C—H⋯O and C—H⋯N hydrogen bonds, forming a three-dimensional framework. In the crystal of (II), mol­ecules are linked by N—H⋯N hydrogen bonds, forming chains propagating along the [010] direction. The chains are linked by a weaker N—H⋯N hydrogen bond, forming layers parallel to the (101) plane, which are in turn linked by C—H⋯O hydrogen bonds, forming a three-dimensional structure. In the crystal of compound (I), a region of disordered electron density was treated with the SQUEEZE routine in PLATON [Spek (2015 ▸). Acta Cryst. C71, 9–18]. Their contribution was not taken into account during refinement. In compound (II), one of the pyridine rings is positionally disordered, and the refined occupancy ratio for the disordered C(ar)—C(ar)—N(py) atoms is 0.58 (3):0.42 (3). International Union of Crystallography 2017-01-31 /pmc/articles/PMC5290586/ /pubmed/28217363 http://dx.doi.org/10.1107/S205698901700127X Text en © Cati and Stoeckli-Evans 2017 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.http://creativecommons.org/licenses/by/2.0/uk/
spellingShingle Research Communications
Cati, Dilovan S.
Stoeckli-Evans, Helen
Crystal structures of N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-2-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide and N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-4-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide
title Crystal structures of N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-2-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide and N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-4-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide
title_full Crystal structures of N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-2-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide and N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-4-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide
title_fullStr Crystal structures of N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-2-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide and N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-4-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide
title_full_unstemmed Crystal structures of N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-2-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide and N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-4-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide
title_short Crystal structures of N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-2-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide and N (2),N (3),N (5),N (6)-tetra­kis­(pyridin-4-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide
title_sort crystal structures of n (2),n (3),n (5),n (6)-tetra­kis­(pyridin-2-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide and n (2),n (3),n (5),n (6)-tetra­kis­(pyridin-4-ylmeth­yl)pyrazine-2,3,5,6-tetra­carboxamide
topic Research Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5290586/
https://www.ncbi.nlm.nih.gov/pubmed/28217363
http://dx.doi.org/10.1107/S205698901700127X
work_keys_str_mv AT catidilovans crystalstructuresofn2n3n5n6tetrakispyridin2ylmethylpyrazine2356tetracarboxamideandn2n3n5n6tetrakispyridin4ylmethylpyrazine2356tetracarboxamide
AT stoecklievanshelen crystalstructuresofn2n3n5n6tetrakispyridin2ylmethylpyrazine2356tetracarboxamideandn2n3n5n6tetrakispyridin4ylmethylpyrazine2356tetracarboxamide